TB time-bomb

The Financial Express - - COMPANIES -

Apro­pos of the edit “Treat­ing TB”, the gov­ern­ment must take great care to en­sure that the roll­out of be­daquiline in the coun­try stays im­mune from the habits of TB pa­tients re­gard­ing drug ad­min­is­tra­tion that have driven the rise of MDR and XDR TB. Pa­tients of­ten dis­con­tinue the medicine upon vis­i­ble relief from the dis­ease, mis­tak­ing that for a full cure. With be­daquiline, we have a hope of bring­ing down and even­tu­ally elim­i­nat­ing XDR and MDR TB and the strains of the TB pathogen that have de­vel­oped re­sis­tance. If In­dia doesn’t pay heed to this, we may soon have a dead­lier strain spread­ing and even worse form of drug re­sis­tance. In a coun­try where sev­eral thou­sands die of tu­ber­cu­lo­sis, any neg­li­gence can be costly. The Edi­tor, TheFi­nan­cialEx­press, B1/B, Sec­tor - 10, Noida - 201301. Distt: Gau­tam Budh Na­gar

(U.P.).or e-mail at: felet­ters@ex­pressin­dia.com or fax at Delhi: 0120-4367933

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.